Table 2 Patient’s follow-up
Patient characteristics | No. of patients (%) |
|---|---|
Number | 82 |
Median follow-up | 60 months (range: 8–128) |
Incomplete response to RT or CRT | 5 (6.1%) |
Recurrence | 15 (18.3%) |
Resectable loco-regional recurrence | 9 |
Unresectable metastatic recurrence | 5 |
Resectable metastatic recurrence | 1 |
Death | 20 (24.4%) |
In relation with anal cancer | 15 |
In relation with another cause | 5 |